Abstract
The regulator of G protein signaling 10 (RGS10) protein is a GTPase activating protein that accelerates the hydrolysis of GTP and therefore canonically inactivates G proteins, ultimately terminating signaling. Rheb is a small GTPase protein that shuttles between its GDP- and GTP-bound forms to activate mTOR. Since RGS10 suppression augments ovarian cancer cell viability, we sought to elucidate the molecular mechanism. Following RGS10 suppression in serum-free conditions, phosphorylation of mTOR, the eukaryotic translation initiation factor 4E binding protein 1 (4E-BP1), p70S6K and S6 Ribosomal Protein appear. Furthermore, suppressing RGS10 increases activated Rheb, suggesting RGS10 antagonizes mTOR signaling via the small G-protein. The effects of RGS10 suppression are enhanced after stimulating cells with the growth factor, lysophosphatidic acid, and reduced with mTOR inhibitors, temsirolimus and INK-128. Suppression of RGS10 leads to an increase in cell proliferation, even in the presence of etoposide. In summary, the RGS10 suppression increases Rheb-GTP and mTOR signaling in ovarian cancer cells. Our results suggest that RGS10 could serve in a novel, and previously unknown, role by accelerating the hydrolysis of GTP from Rhe...Continue Reading
References
Sep 12, 1996·Nature·T W HuntE G Peralta
May 29, 2003·Nature Cell Biology·Yong ZhangDuojia Pan
Jul 19, 2003·Genes & Development·Ken InokiKun-Liang Guan
Aug 9, 2003·Current Biology : CB·Andrew R TeeJohn Blenis
Dec 5, 2003·Nucleic Acids Research·Xiaowei Wang, Brian Seed
Feb 11, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yoonseok Kam, John H Exton
Apr 28, 2005·Current Biology : CB·Xiaomeng LongJoseph Avruch
Jun 14, 2005·International Journal of Biological Sciences·David P Siderovski, Francis S Willard
Aug 16, 2005·FEBS Letters·Andrew R TeeChristopher G Proud
Sep 17, 2005·Cancer Research·Junji TsurutaniPhillip A Dennis
Aug 19, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M BeeramL A DeGraffenried
Oct 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chien-Hsing LuDihua Yu
Apr 17, 2008·Cancer Research·Boris ShorKer Yu
Jun 4, 2008·Oncogene·H Jiang, P K Vogt
Aug 20, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Seiji MabuchiTadashi Kimura
Dec 1, 2009·Current Opinion in Cell Biology·Alejo Efeyan, David M Sabatini
Apr 7, 2010·Cellular Signalling·Nan SethakornNickolai O Dulin
Nov 4, 2010·Molecular Cancer·Shelley B HooksMandi M Murph
Feb 16, 2011·Molecular and Cellular Biology·Susanna M I GoordenYpe Elgersma
Oct 26, 2011·Molecular Cancer Research : MCR·Wei JiaMandi M Murph
Jul 14, 2012·Biochemistry Research International·Molly K AltmanMandi M Murph
Feb 7, 2013·Molecular Cancer Research : MCR·Yanan Guo, David J Kwiatkowski
Mar 28, 2013·PloS One·Mourad W AliShelley B Hooks
Apr 30, 2013·PloS One·C Aaron MonroyDavid L Roman
Jan 7, 2014·PloS One·Chih-Chieh WangBenjamin J Hall
Jan 9, 2014·Cancer Research·Esther Lopez-RiveraAndrew G Sikora
Aug 2, 2014·Nature Cell Biology·Sandra S McAllister, Robert A Weinberg
Sep 18, 2014·PloS One·Corine M BeaufortJozien Helleman
Citations
Sep 16, 2016·Journal of Drug Targeting·Azam Roohi, Mohammad Hojjat-Farsangi
Jun 7, 2018·Pharmacological Reviews·Katherine E SquiresJohn R Hepler
Dec 13, 2019·Cerebral Cortex·Jian-Wei ZhuRu-Xiang Xu
Oct 23, 2019·The Journal of Biological Chemistry·Joseph B O'BrienDavid L Roman
Apr 13, 2021·Genomics·Yuexin HuBei Lin
Aug 3, 2021·Cellular Signalling·Faris AlmutairiBalázs Rada
Nov 6, 2021·Experimental and Therapeutic Medicine·Gaoting QuAiqing Zhang